BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10510456)

  • 1. Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.
    Walker BD; Singleton CB; Bursill JA; Wyse KR; Valenzuela SM; Qiu MR; Breit SN; Campbell TJ
    Br J Pharmacol; 1999 Sep; 128(2):444-50. PubMed ID: 10510456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
    Mohammad S; Zhou Z; Gong Q; January CT
    Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
    Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
    Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
    Teschemacher AG; Seward EP; Hancox JC; Witchel HJ
    Br J Pharmacol; 1999 Sep; 128(2):479-85. PubMed ID: 10510461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.
    Potet F; Bouyssou T; Escande D; Baró I
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1007-12. PubMed ID: 11714889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
    Chen J; Seebohm G; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12461-6. PubMed ID: 12209010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
    Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HERG potassium channels by the antimalarial agent halofantrine.
    Tie H; Walker BD; Singleton CB; Valenzuela SM; Bursill JA; Wyse KR; Breit SN; Campbell TJ
    Br J Pharmacol; 2000 Aug; 130(8):1967-75. PubMed ID: 10952689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders.
    Drolet B; Rousseau G; Daleau P; Cardinal R; Turgeon J
    Circulation; 2000 Oct; 102(16):1883-5. PubMed ID: 11034933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
    Caballero R; Moreno I; González T; Arias C; Valenzuela C; Delpón E; Tamargo J
    Circulation; 2003 Feb; 107(6):889-95. PubMed ID: 12591761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
    Ficker E; Obejero-Paz CA; Zhao S; Brown AM
    J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
    Rampe D; Murawsky MK; Grau J; Lewis EW
    J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
    Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
    J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
    Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
    Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human ether-à-go-go-related gene K+ channel gating probed with extracellular ca2+. Evidence for two distinct voltage sensors.
    Johnson JP; Mullins FM; Bennett PB
    J Gen Physiol; 1999 Apr; 113(4):565-80. PubMed ID: 10102937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel extracellular calcium sensing mechanism in voltage-gated potassium ion channels.
    Johnson JP; Balser JR; Bennett PB
    J Neurosci; 2001 Jun; 21(12):4143-53. PubMed ID: 11404399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects.
    Zhou Z; Gong Q; January CT
    J Biol Chem; 1999 Oct; 274(44):31123-6. PubMed ID: 10531299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.